Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL GLUTATHIONE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL GLUTATHIONE MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES
2.2.8 CONSUMPTION TREND OF END PRODUCTS
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 STANDARDS OF MEASUREMENT
2.2.11 VENDOR SHARE ANALYSIS
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL GLUTATHIONE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 VALUE CHAIN ANALYSIS
5.2 SUPPLY CHAIN ANALYSIS
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 BARGAINING POWER OF SUPPLIERS
5.3.2 BARGAINING POWER OF BUYERS/CONSUMERS
5.3.3 THREAT OF NEW ENTRANTS
5.3.4 THREAT OF SUBSTITUTE PRODUCTS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5.5 OVERVIEW ON TECHNOLOGICAL INNOVATIONS
5.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE
5.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS
6 REGULATORY FRAMEWORK AND GUIDELINES
7 PRICING ANALYSIS
8 GLOBAL GLUTATHIONE MARKET, BY TYPE, 2022-2031, (USD MILLION) (KILO TONS)
8.1 OVERVIEW
8.2 GLUTATHIONE OXIDIZED
8.3 GLUTATHIONE REDUCED
9 GLOBAL GLUTATHIONE MARKET, BY PURITY, 2022-2031, (USD MILLION)
9.1 <99%
9.2 =>99%
10 GLOBAL GLUTATHIONE MARKET, BY APPLICATION, 2022-2031, (USD MILLION)
10.1 OVERVIEW
10.2 FOOD AND BEVERAGES
10.2.1 FUNCTIONAL FOODS
10.2.2 BEVERAGES
10.2.2.1. FRUIT JUICES
10.2.2.2. SMOOTHIES
10.2.2.3. FUNCTIONAL DRINK
10.2.2.4. OTHERS
10.2.3 FOOD ADDITIVES
10.2.3.1. PROCESSED FOODS
10.2.3.2. BAKED GOODS
10.2.3.3. MEAT PRODUCTS
10.2.3.4. OTHERS
10.2.4 OTHERS
10.3 NUTRACEUTICALS
10.4 MEDICAL
10.4.1 RESPIRATORY HEALTH
10.4.2 INTRAVENOUS (IV) THERAPY
10.4.3 CHRONIC ILLNESS MANAGEMENT
10.4.4 OTHERS
10.5 SPORTS NUTRITION
10.6 COSMETICS (SKIN CARE)
10.6.1 CREAM
10.6.2 LOTION
10.6.3 SERUM
10.6.4 OTHERS
10.7 PHARMACEUTICALS
10.7.1 SYRUPS
10.7.2 TABLETS
10.7.3 OTHERS
10.8 OTHERS
11 GLOBAL GLUTATHIONE MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
11.5 MERGERS & ACQUISITIONS
11.6 NEW PRODUCT DEVELOPMENT & APPROVALS
11.7 EXPANSIONS & PARTNERSHIP
11.8 REGULATORY CHANGES
12 GLOBAL GLUTATHIONE MARKET, BY GEOGRAPHY, 2022-2031 (USD MILLION) (KILO TONS)
OVERVIEW (ALL SEGMENTATION PROVIDED ABOVE IS REPRESNTED IN THIS CHAPTER BY COUNTRY)
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
12.2 EUROPE
12.2.1 GERMANY
12.2.2 U.K.
12.2.3 ITALY
12.2.4 FRANCE
12.2.5 SPAIN
12.2.6 SWITZERLAND
12.2.7 NETHERLAND
12.2.8 BELGIUM
12.2.9 RUSSIA
12.2.10 TURKEY
12.2.11 NORWAY
12.2.12 FINLAND
12.2.13 SWEDEN
12.2.14 DENMARK
12.2.15 POLAND
12.2.16 REST OF EUROPE
12.3 ASIA-PACIFIC
12.3.1 JAPAN
12.3.2 CHINA
12.3.3 SOUTH KOREA
12.3.4 INDIA
12.3.5 AUSTRALIA
12.3.6 SINGAPORE
12.3.7 THAILAND
12.3.8 INDONESIA
12.3.9 MALAYSIA
12.3.10 PHILIPPINES
12.3.11 TAIWAN
12.3.12 VIETNAM
12.3.13 NEW ZEALAND
12.3.14 REST OF ASIA-PACIFIC
12.4 SOUTH AMERICA
12.4.1 BRAZIL
12.4.2 ARGENTINA
12.4.3 REST OF SOUTH AMERICA
12.5 MIDDLE EAST AND AFRICA
12.5.1 SOUTH AFRICA
12.5.2 UAE
12.5.3 QATAR
12.5.4 SAUDI ARABIA
12.5.5 KUWAIT
12.5.6 EGYPT
12.5.7 ISRAEL
12.5.8 OMAN
12.5.9 BAHRAIN
12.5.10 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL GLUTATHIONE MARKET, SWOT & DBMR ANALYSIS
14 GLOBAL GLUTATHIONE MARKET, COMPANY PROFILES
14.1 KYOWA HAKKO U.S.A., INC.
14.1.1 COMPANY OVERVIEW
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD
14.2.1 COMPANY OVERVIEW
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 KOHJIN LIFE SCIENCES CO.,LTD.
14.3.1 COMPANY OVERVIEW
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 SHENZHEN GSH BIO-TECHNOLOGY CO., LTD
14.4.1 COMPANY OVERVIEW
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 KAIPING GENUINE BIOCHEMICAL PHARMACEUTICAL CO., LTD
14.5.1 COMPANY OVERVIEW
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 GSH BIO-TECH
14.6.1 COMPANY OVERVIEW
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 HERBO NUTRA
14.7.1 COMPANY OVERVIEW
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 HAIHANG INDUSTRY
14.8.1 COMPANY OVERVIEW
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 METEORIC BIOPHARMACEUTICALS LIMITED
14.9.1 COMPANY OVERVIEW
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 FABRICHEM
14.10.1 COMPANY OVERVIEW
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 HUNAN BIO-ESSENTIAL TECH CO., LTD.
14.11.1 COMPANY OVERVIEW
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENTS
14.12 VIVAN LIFE SCIENCES
14.12.1 COMPANY OVERVIEW
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.13 MCLS EUROPE B.V.
14.13.1 COMPANY OVERVIEW
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 FIDO PHARMA PVT. LTD.
14.14.1 COMPANY OVERVIEW
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENTS
14.15 GNOSIS
14.15.1 COMPANY OVERVIEW
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENTS
14.16 LIPOCELLTECH
14.16.1 COMPANY OVERVIEW
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.17 PLAMED GREEN SCIENCE GROUP
14.17.1 COMPANY OVERVIEW
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 YR CHEMSPEC
14.18.1 COMPANY OVERVIEW
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 XI'AN LE-NUTRA INGREDIENTS INC.
14.19.1 COMPANY OVERVIEW
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 FENGCHEN GROUP CO.,LTD
14.20.1 COMPANY OVERVIEW
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
14.21 HEBEI GUANLANG BIOTECHNOLOGY CO., LTD.
14.21.1 COMPANY OVERVIEW
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
14.22 OTTO CHEMIE PVT. LTD
14.22.1 COMPANY OVERVIEW
14.22.2 REVENUE ANALYSIS
14.22.3 PRODUCT PORTFOLIO
14.22.4 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
15 RELATED REPORTS
16 QUESTIONNAIRE
17 ABOUT DATA BRIDGE MARKET RESEARCH
